• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrazolopyridines

3-Bromo-5-Fluoro-1H-Pyrazolo[3,4-B]Pyridine: A Comprehensive Overview

3-Bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine, identified by the CAS number CAS No. 1256822-80-6, is a heterocyclic aromatic compound that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound is characterized by its unique pyrazolo[3,4-b]pyridine scaffold, which incorporates bromine and fluorine substituents at the 3 and 5 positions, respectively. The combination of these substituents imparts distinctive electronic and steric properties to the molecule, making it a valuable building block in drug discovery and materials science.

The synthesis of 3-bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine typically involves multi-step processes that leverage advanced methodologies in organic synthesis. Recent advancements have focused on optimizing reaction conditions to enhance yield and purity while minimizing environmental impact. For instance, researchers have explored the use of microwave-assisted synthesis and catalytic systems to streamline the production of this compound. These methods not only improve efficiency but also align with the principles of green chemistry.

In terms of applications, 3-bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine has shown promise in various therapeutic areas. Its ability to modulate key biological targets, such as kinases and G-protein coupled receptors (GPCRs), has made it a subject of interest in drug development. Recent studies have demonstrated its potential as a lead compound for treating conditions like cancer and neurodegenerative diseases. For example, a 2023 study published in Nature Communications highlighted its role in inhibiting a novel kinase pathway associated with glioblastoma multiforme.

The structural versatility of CAS No. 1256822-80-6 also extends to its use in materials science. Its aromaticity and heteroatom content make it suitable for applications in organic electronics and optoelectronics. Researchers have investigated its potential as a component in organic light-emitting diodes (OLEDs) and photovoltaic devices. Preliminary results indicate that it could enhance device performance by improving charge transport properties.

From a pharmacokinetic standpoint, 3-bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine exhibits favorable absorption profiles in preclinical models. Studies conducted in rodents suggest that it achieves systemic concentrations sufficient for therapeutic efficacy without inducing significant toxicity. However, further research is required to evaluate its long-term safety profile and potential for bioaccumulation.

In conclusion, CAS No. 1256822-80-6, or 3-bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine, represents a versatile compound with diverse applications across multiple scientific disciplines. Its unique chemical structure and promising biological activity position it as a valuable tool for advancing both medical treatments and technological innovations. As research continues to uncover its full potential, this compound is poised to play an increasingly important role in the development of novel therapies and materials.

• 1357945-93-7(3,6-Dibromo-1H-pyrazolo[3,4-b]pyridine)
• 1357945-12-0(3,4-dibromo-2h-pyrazolo[3,4-b]pyridine)
• 68618-36-0(3-Bromo-1H-pyrazolo[3,4-b]pyridine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)